Rate My Professor Andrew Morris

Professor Andrew Morris serves as Head of Pharmacy and Professor of Pharmacy Education within Swansea University Medical School, leading the pharmacy team in developing the UK’s newest MPharm programme. His research interests focus on drug delivery and tissue engineering, pharmacy and medical education, and health data science. He maintains a strong interest in the internationalisation of higher education and leads internationalisation for the Medical School. Previously, he was Dean of the Faculty of Science at the University of Nottingham Malaysia Campus (2016-2018), where he contributed to establishing the first GPhC-accredited MPharm degree delivered in part outside the UK. He also served as Head of School and Professor (2016-2018), Associate Professor (2010-2016), and Assistant Professor (2009-2010) there. Prior to academia, he practised as a community pharmacist locum in South Wales and West Midlands (2005-2008) and as Community Pharmacy and Prescribing Advisor for NHS Wales (1999-2006). He is a registered pharmacist with the GPhC, a founding member of the Royal Pharmaceutical Society, and a Fellow of the Higher Education Academy. He completed his PhD at Cardiff University (1999-2003).

At Swansea University since 2018, Andrew Morris is a member of the University Senate (2019-present). His key publications include Nair, Billa, & Morris, 'Optimizing In Vitro Skin Permeation Studies to Obtain Meaningful Data in Topical and Transdermal Drug Delivery' (AAPS PharmSciTech, 2021); Kaur et al., 'Biomedical Applications of polymeric micelles in the treatment of diabetes mellitus: Current success and future approaches' (Expert Opinion on Drug Delivery, 2022); Torabi et al., 'Impact of COVID-19 pandemic on community medication dispensing: a national cohort analysis in Wales, UK' (International Journal of Population Data Science, 2021); Nair, Billa, Mooi, & Morris, 'Characterization and ex vivo evaluation of curcumin nanoethosomes for melanoma treatment' (Pharmaceutical Development and Technology, 2022); and Nair et al., 'An evaluation of tocotrienol ethosomes for transdermal delivery using Strat-M® membrane and excised human skin' (Pharmaceutical Development and Technology, 2021). These contributions underscore his influence in transdermal drug delivery, pharmacy education, and health data applications.